Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Latest filing published 15 Feb 2022 for Cullinan Oncology, Inc.. Read the official filing
Filing timeline
BuySaleLeigh Zawel
Insider track record
Disclosed buys
0
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Leigh Zawel: trading record in brief
This profile gathers the share dealings of Leigh Zawel in Cullinan Therapeutics, Inc. In total, 9 filings cover trades dated from 9 August 2021 to 11 February 2022.
Every open-market trade on record is a sale: 8 sales worth €3.6M. Outside the open market, there are 1 share grant.
On 15 February 2022 came the latest disclosure, a share grant in Cullinan Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Leigh Zawel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
32,500 shares0Common StockSEC:0000899243-22-006417:0
19,574 shares@ US$25.0017.4% of flowCommon StockSEC:0000899243-21-040453:0
1,079 shares@ US$25.001.0% of flowCommon StockSEC:0000899243-21-039858:0
7,468 shares@ US$25.166.6% of flowCommon StockSEC:0000899243-21-036781:0
28,118 shares@ US$28.9528.3% of flowCommon StockSEC:0000899243-21-035331:0
19,504 shares@ US$26.520.046% mcap6.2% of flowCommon StockSEC:0000899243-21-034314:0
28,118 shares@ US$29.000.072% mcap9.7% of flowCommon StockSEC:0000899243-21-034311:0
28,118 shares@ US$29.0028.6% of flowCommon StockSEC:0000899243-21-034027:0
19,504 shares@ US$26.5218.1% of flowCommon StockSEC:0000899243-21-032515:0
9 of 9 declarations
